INCR Stock Summary and Trading Ideas (Intercure Ltd. - | NASDAQ:INCR)

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Intercure Ltd. - trades on the NASDAQ stock market under the symbol INCR.

As of July 20, 2026, INCR stock price declined to $0.91 with 14,366 million shares trading.

INCR has a beta of 0.90, meaning it tends to be less sensitive to market movements. INCR has a correlation of 0.04 to the broad based SPY ETF.

INCR has a market cap of $52.01 million. This is considered a Micro Cap stock.

In the last 3 years, INCR traded as high as $3.72 and as low as $.68.

INCR has underperformed the market in the last year with a price return of -39.3% while the SPY ETF gained +19.4%. However, in the short term, INCR had mixed performance relative to the market. It has outperformed in the last 3 months, returning +18.2% vs +4.8% return in SPY. But in the last 2 weeks, INCR shares have been beat by the market, returning -16.5% compared to an SPY return of -0.4%.

INCR support price is $.87 and resistance is $.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INCR shares will trade within this expected range on the day.